PENUMBRA INC (PEN) Stock Fundamental Analysis
NYSE:PEN - New York Stock Exchange, Inc. - US70975L1070 - Common Stock
Overall PEN gets a fundamental rating of 6 out of 10. We evaluated PEN against 191 industry peers in the Health Care Equipment & Supplies industry. While PEN has a great health rating, its profitability is only average at the moment. PEN is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make PEN suitable for growth investing!
1. Profitability
1.1 Basic Checks
PEN had positive earnings in the past year.
PEN had a positive operating cash flow in the past year.
In multiple years PEN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: PEN reported negative operating cash flow in multiple years.
1.2 Ratios
PEN's Return On Assets of 2.34% is fine compared to the rest of the industry. PEN outperforms 74.21% of its industry peers.
PEN has a Return On Equity of 3.13%. This is in the better half of the industry: PEN outperforms 75.26% of its industry peers.
PEN has a better Return On Invested Capital (6.66%) than 83.68% of its industry peers.
PEN had an Average Return On Invested Capital over the past 3 years of 2.28%. This is significantly below the industry average of 8.08%.
The last Return On Invested Capital (6.66%) for PEN is above the 3 year average (2.28%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.13% | ||
| ROIC | 6.66% |
ROA(3y)2.04%
ROA(5y)2.3%
ROE(3y)2.69%
ROE(5y)3.12%
ROIC(3y)2.28%
ROIC(5y)N/A
1.3 Margins
PEN has a Profit Margin of 2.97%. This is in the better half of the industry: PEN outperforms 73.68% of its industry peers.
PEN's Profit Margin has improved in the last couple of years.
PEN has a Operating Margin of 9.61%. This is in the better half of the industry: PEN outperforms 78.42% of its industry peers.
PEN's Operating Margin has improved in the last couple of years.
The Gross Margin of PEN (65.70%) is better than 69.47% of its industry peers.
PEN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.61% | ||
| PM (TTM) | 2.97% | ||
| GM | 65.7% |
OM growth 3YN/A
OM growth 5Y5.22%
PM growth 3YN/A
PM growth 5Y42.09%
GM growth 3Y2.24%
GM growth 5Y-0.38%
2. Health
2.1 Basic Checks
PEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PEN has more shares outstanding
PEN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PEN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 18.14 indicates that PEN is not in any danger for bankruptcy at the moment.
PEN has a better Altman-Z score (18.14) than 93.16% of its industry peers.
The Debt to FCF ratio of PEN is 0.18, which is an excellent value as it means it would take PEN, only 0.18 years of fcf income to pay off all of its debts.
PEN has a Debt to FCF ratio of 0.18. This is amongst the best in the industry. PEN outperforms 92.11% of its industry peers.
PEN has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
PEN has a better Debt to Equity ratio (0.02) than 64.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.18 | ||
| Altman-Z | 18.14 |
ROIC/WACC0.72
WACC9.24%
2.3 Liquidity
PEN has a Current Ratio of 5.82. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.82, PEN belongs to the best of the industry, outperforming 82.11% of the companies in the same industry.
PEN has a Quick Ratio of 3.25. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
PEN has a better Quick ratio (3.25) than 68.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.82 | ||
| Quick Ratio | 3.25 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 78.52% over the past year.
Measured over the past years, PEN shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.59% on average per year.
Looking at the last year, PEN shows a quite strong growth in Revenue. The Revenue has grown by 16.96% in the last year.
Measured over the past years, PEN shows a quite strong growth in Revenue. The Revenue has been growing by 18.93% on average per year.
EPS 1Y (TTM)78.52%
EPS 3Y126.44%
EPS 5Y32.59%
EPS Q2Q%26.87%
Revenue 1Y (TTM)16.96%
Revenue growth 3Y23.61%
Revenue growth 5Y18.93%
Sales Q2Q%11.11%
3.2 Future
The Earnings Per Share is expected to grow by 29.72% on average over the next years. This is a very strong growth
PEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.32% yearly.
EPS Next Y35.07%
EPS Next 2Y35.75%
EPS Next 3Y33.99%
EPS Next 5Y29.72%
Revenue Next Year12.23%
Revenue Next 2Y13.35%
Revenue Next 3Y13.67%
Revenue Next 5Y13.32%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 103.11 indicates a quite expensive valuation of PEN.
Based on the Price/Earnings ratio, PEN is valued a bit cheaper than 65.26% of the companies in the same industry.
When comparing the Price/Earnings ratio of PEN to the average of the S&P500 Index (28.29), we can say PEN is valued expensively.
PEN is valuated quite expensively with a Price/Forward Earnings ratio of 71.21.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 68.42% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.44. PEN is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 103.11 | ||
| Fwd PE | 71.21 |
4.2 Price Multiples
PEN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PEN is cheaper than 64.74% of the companies in the same industry.
PEN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PEN is cheaper than 70.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 78.45 | ||
| EV/EBITDA | 72.49 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as PEN's earnings are expected to grow with 33.99% in the coming years.
PEG (NY)2.94
PEG (5Y)3.16
EPS Next 2Y35.75%
EPS Next 3Y33.99%
5. Dividend
5.1 Amount
No dividends for PEN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PENUMBRA INC
NYSE:PEN (1/22/2025, 11:30:59 AM)
274.26
+6.06 (+2.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners93.36%
Inst Owner Change0%
Ins Owners3.8%
Ins Owner Change0.68%
Market Cap10.53B
Analysts80.87
Price Target264.18 (-3.68%)
Short Float %4.98%
Short Ratio4.92
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.03%
Min EPS beat(2)13.6%
Max EPS beat(2)22.45%
EPS beat(4)4
Avg EPS beat(4)12.73%
Min EPS beat(4)7.31%
Max EPS beat(4)22.45%
EPS beat(8)8
Avg EPS beat(8)33.42%
EPS beat(12)10
Avg EPS beat(12)20.39%
EPS beat(16)13
Avg EPS beat(16)68.98%
Revenue beat(2)1
Avg Revenue beat(2)-0.21%
Min Revenue beat(2)-0.64%
Max Revenue beat(2)0.22%
Revenue beat(4)2
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-1.64%
Max Revenue beat(4)0.37%
Revenue beat(8)6
Avg Revenue beat(8)0.81%
Revenue beat(12)8
Avg Revenue beat(12)1.12%
Revenue beat(16)12
Avg Revenue beat(16)2.67%
PT rev (1m)9.98%
PT rev (3m)26.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.03%
EPS NY rev (1m)0%
EPS NY rev (3m)6.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 103.11 | ||
| Fwd PE | 71.21 | ||
| P/S | 9.04 | ||
| P/FCF | 78.45 | ||
| P/OCF | 68.51 | ||
| P/B | 9.53 | ||
| P/tB | 11.31 | ||
| EV/EBITDA | 72.49 |
EPS(TTM)2.66
EY0.97%
EPS(NY)3.85
Fwd EY1.4%
FCF(TTM)3.5
FCFY1.27%
OCF(TTM)4
OCFY1.46%
SpS30.32
BVpS28.77
TBVpS24.26
PEG (NY)2.94
PEG (5Y)3.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.13% | ||
| ROCE | 8.43% | ||
| ROIC | 6.66% | ||
| ROICexc | 8.54% | ||
| ROICexgc | 10.25% | ||
| OM | 9.61% | ||
| PM (TTM) | 2.97% | ||
| GM | 65.7% | ||
| FCFM | 11.53% |
ROA(3y)2.04%
ROA(5y)2.3%
ROE(3y)2.69%
ROE(5y)3.12%
ROIC(3y)2.28%
ROIC(5y)N/A
ROICexc(3y)2.88%
ROICexc(5y)N/A
ROICexgc(3y)3.74%
ROICexgc(5y)N/A
ROCE(3y)2.89%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-5.74%
ROICexc growth 3YN/A
ROICexc growth 5Y-7.37%
OM growth 3YN/A
OM growth 5Y5.22%
PM growth 3YN/A
PM growth 5Y42.09%
GM growth 3Y2.24%
GM growth 5Y-0.38%
F-Score7
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.18 | ||
| Debt/EBITDA | 0.16 | ||
| Cap/Depr | 73.83% | ||
| Cap/Sales | 1.67% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 111.18% | ||
| Profit Quality | 388.4% | ||
| Current Ratio | 5.82 | ||
| Quick Ratio | 3.25 | ||
| Altman-Z | 18.14 |
F-Score7
WACC9.24%
ROIC/WACC0.72
Cap/Depr(3y)88.08%
Cap/Depr(5y)145.86%
Cap/Sales(3y)2.18%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.52%
EPS 3Y126.44%
EPS 5Y32.59%
EPS Q2Q%26.87%
EPS Next Y35.07%
EPS Next 2Y35.75%
EPS Next 3Y33.99%
EPS Next 5Y29.72%
Revenue 1Y (TTM)16.96%
Revenue growth 3Y23.61%
Revenue growth 5Y18.93%
Sales Q2Q%11.11%
Revenue Next Year12.23%
Revenue Next 2Y13.35%
Revenue Next 3Y13.67%
Revenue Next 5Y13.32%
EBIT growth 1Y81.85%
EBIT growth 3YN/A
EBIT growth 5Y25.14%
EBIT Next Year85.52%
EBIT Next 3Y43.29%
EBIT Next 5Y32.8%
FCF growth 1Y248.93%
FCF growth 3YN/A
FCF growth 5Y33.72%
OCF growth 1Y331.83%
OCF growth 3YN/A
OCF growth 5Y27.57%